Anzeige
Mehr »
Login
Dienstag, 30.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Uran Boom: Die Bullen starten durch - spektakuläre Kursgewinne möglich
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
33 Leser
Artikel bewerten:
(0)

Global PCR Product Market Worth $9.8 Billion by 2021 - Segmentation By Application & Technology - Research and Markets

DUBLIN, August 22, 2016 /PRNewswire/ --

Research and Markets has announced the addition of the "Polymerase Chain Reaction (PCR) Technologies and Global Markets" report to their offering.

This report focuses on the global market of PCR products and provides an updated review of the technology's basic design and its applications in the arenas of biomedical and life science research. The report covers the total market for PCR products, which includes instruments, reagents, consumables and accessories, software and services.

The applications included are research applications, clinical applications and other applications (detection of pathogens like fungus and parasites in animals and plants). These categories are further subdivided into types, i.e., types of instruments. The report also covers the market of PCR products by technology, which includes thermal cyclers, real-time PCR, reverse transcriptase (RT) PCR, inverse and standard PCR, assembly and nested PCR, hot start and touchdown PCR, multiplex and other PCR.

The reagent market includes individual reagents (such as buffers, dNTPs, controls templates, enzymes, primers and probes), master mixes and kits and other reagents such as PCR calibration kits and PCR cleanup kits. The consumables market includes plates and frames, PCR tubes, PCR sealers and plastics. The PCR software market includes primer design and sequencing software, PCR analyzer software, integrated software and others.

Companies Mentioned:

  • Abbott Laboratories
  • Affymetrix Inc.
  • Agilent Technologies Inc.
  • Alphahelix Molecular Diagnostics AB
  • Amplicon Express Inc.
  • Anaspec Inc. (Eurogentec Group)
  • Beckman Coulter Inc.
  • Becton, Dickinson & Co.
  • Bioline GMBH
  • Bioneer Corp.
  • Biofire Diagnostics Llc
  • Bio-Rad Laboratories Inc.
  • Complete Genomics Inc.
  • Elitech Group Molecular Diagnostics
  • Eppendorf AG
  • Exiqon
  • F. Hoffman-La Roche Ltd.
  • Ge Electric Healthcare Life Sciences.
  • Kapa Biosystems Inc.
  • Lucigen Corp.
  • Luminex Corp.
  • New England Biolabs
  • Promega Corp.
  • Qiagen N.V.
  • Quanta Biosciences Inc.
  • Sigma-Aldrich Corp.
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.

Key Topics Covered:

1: Introduction

2: Executive Summary

3: Overview

4: Regulatory Approvals

5: New Developments

6: Market Analysis

7: Industry Structure

8: Market By Application And Technology

9: Patent Analysis

10: Current Situation

11: Company Profiles

12: Appendix I-Abbreviations

For more information about this report visit http://www.researchandmarkets.com/research/r9gm92/polymerase_chain

Related Topics: Infectious Disease Testing, Enzymes , Molecular Diagnostics

Media Contact:

Research and Markets

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470

For U.S./CAN Toll Free Call +1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907

Fax (outside U.S.): +353-1-481-1716

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2016 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.